Clinical outcomes of left main coronary artery disease patients undergoing three different revascularization

Chieh-Shou Su1, Yu-Wei Chen, Ching-Hui Shen

  • 1Cardiovascular Center, Taichung Veterans General Hospital, Taichung Institute of Clinical Medicine, and Department of Medicine, National Yang-Ming University School of Medicine, Taipei Division of Cardiology, Department of Internal Medicine, Taichung Veterans General Hospital Chiayi Branch, Chiayi Department of Anesthesiology, Taichung Veterans General Hospital, Taichung Department of Surgery Department of Medicine, National Yang Ming University School of Medicine, Taipei, Taiwan.

Medicine
|February 15, 2018
PubMed

Insights

Robot-assisted coronary artery bypass grafting (R-CABG) showed lower mortality and shorter hospital stays for left main (LM) coronary artery disease patients compared to conventional CABG and PCI. R-CABG is a viable option for selected LM disease patients.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Interventional Cardiology

Background:

  • Left main (LM) coronary artery disease significantly increases mortality and morbidity risk.
  • Revascularization strategies for LM disease include percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To compare the clinical outcomes of PCI, conventional CABG (C-CABG), and robot-assisted CABG (R-CABG) in patients with LM disease.

Main Methods:

  • Retrospective analysis of 472 LM disease patients undergoing PCI, C-CABG, or R-CABG between 2005 and 2013.
  • Comparison of in-hospital and follow-up outcomes, including mortality, target vessel revascularization (TVR), and resource utilization.

Main Results:

  • R-CABG group demonstrated significantly lower in-hospital and follow-up all-cause deaths compared to PCI and C-CABG groups.
  • PCI group had the highest rate of TVR.
  • R-CABG patients experienced shorter ICU and hospital stays and required less intra-aortic balloon pump support than C-CABG patients.

Conclusions:

  • PCI may be suitable for older, comorbid patients with less complex LM disease.
  • R-CABG is a feasible and effective alternative to C-CABG for stable LM disease patients, particularly those with high SYNTAX scores.
  • Revascularization modality was not an independent predictor of long-term mortality in this real-world cohort.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
461